首页 | 本学科首页   官方微博 | 高级检索  
     

甲状腺滤泡癌组织中PD-1和NLRP3表达及其临床意义
引用本文:戴炀斌,邱燕如,江振健,王声耀,戴毅君,林建光. 甲状腺滤泡癌组织中PD-1和NLRP3表达及其临床意义[J]. 中国肿瘤生物治疗杂志, 2022, 29(1): 50-54
作者姓名:戴炀斌  邱燕如  江振健  王声耀  戴毅君  林建光
作者单位:福建医科大学附属第二医院 肿瘤内科,福建 泉州 362000
基金项目:国家卫生健康委员会青年项目(No.2018-2-26);泉州市 科技计划项目(No.2018Z112)
摘    要:目的:探讨甲状腺滤泡癌(FTC)组织中程序性死亡蛋白1(PD-1)和NOD样受体蛋白3(NLRP3)的表达及其与患者临床病理特征和预后的关系。方法:收集2015年1月至2020年6月福建医科大学附属第二医院手术切除的60例FTC患者的癌和配对癌旁组织标本,采用免疫组织化学染色法检测癌及癌旁组织中PD-1和NLRP3的阳性表达率,χ2检验或者Fisher精确检验法分析PD-1和NLRP3表达与FTC患者临床病理特征的关系,Pearson相关性分析PD-1与NLRP3表达的关系,Kaplan-Meier生存和Logistic回归分析PD-1和NLRP3表达与患者预后的关系。结果:在60例FTC组织中,PD-1和NLRP3均有较高的阳性表达率(46.67%与63.33%)。PD-1表达与FTC患者肿瘤分期、肿瘤大小、血管侵犯、复发与否具有显著相关性(均P<0.05),NLRP3表达与患者肿瘤大小、血管侵犯、甲状腺外浸润以及复发具有显著相关性(均P<0.05)。PD-1与NLRP3的表达成负相关,前者与患者更好的预后相关,后者是FTC复发的独立风险因素。结论:...

关 键 词:甲状腺滤泡癌  程序性死亡蛋白1  NOD样受体蛋白3  复发  预后
收稿时间:2021-09-10
修稿时间:2021-12-19

Expression and clinical significance of PD-1 and NLRP3 in follicular thyroid carcinoma tissues
DAI Yangbin,QIU Yanru,JIANG Zhenjian,WANG Shengyao,DAI Yijun,LIN Jianguang. Expression and clinical significance of PD-1 and NLRP3 in follicular thyroid carcinoma tissues[J]. Chinses Journal of Cancer Biotherapy, 2022, 29(1): 50-54
Authors:DAI Yangbin  QIU Yanru  JIANG Zhenjian  WANG Shengyao  DAI Yijun  LIN Jianguang
Affiliation:Department of Oncology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian, China
Abstract:Objective: To investigate the expression of programmed death protein 1(PD-1) and NOD-like receptor protein 3(NLRP3) in follicular thyroid carcinoma(FTC) tissues and their relationship with clinicopathological features and prognosis of patients.Methods: A total of 60 pairs of cancer tissues and corresponding para-cancerous tissues that surgically resected from patients with FTC at the Second Affiliated Hospital of Fujian Medical University from January 2015 to June 2020 were collected for this study. The positive expression rate of PD-1 and NLRP3 was detected by immunohistochemical staining in the cancer and para-cancerous tissues.The relationship between the expression of PD-1, NLRP3 and the clinicopathological characteristics of FTC patients was analyzed by χ;test or Fisher’s exact test. Pearson correlation analysis was used to analyze the relationship between the expression of PD-1 and NLRP3,and Kaplan-Meier survival analysis and Logistic regression analysis were used to analyze the relationship between the expression of PD-1, NLRP3 and the prognosis of FTC patients. Results: High positive expression rates of PD-1 and NLRP3 were observed(46.67%and 63.33%) in the FTC tissues. The expression of PD-1 was significantly correlated with tumor stage, tumor diameter, vascular invasion and recurrence status of FTC patients(all P<0.05), while the expression of NLRP3 was significantly correlated with tumor diameter, vascular invasion, extra-thyroid infiltration and recurrence status of the patients(all P<0.05). The expression of PD-1 was negatively correlated with NLRP3 level. PD-1 was correlated with a better prognosis of patients, while NLRP3 was an independent risk factor for disease recurrence. Conclusion: PD-1 and NLRP3 have high positive expression rate in FTC tissues. The former is associated with better prognosis, while the latter is an independent risk factor for disease recurrence, and the two are negatively correlated.
Keywords:follicular thyroid carcinoma (FTC)   programmed death-1 (PD-1)   NOD-like receptor protein 3 (NLRP3)   recurrence   prognosis
本文献已被 维普 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号